Related Experiment Video
Updated: Jul 26, 2026

08:58
Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood
Published on: April 16, 2016
11.0K
Recent trends in mesoporous carbon-based nanoplatforms for biomedical application
Wei Yang1, Jinnian Ge2, Mohan Jiang3
1Department of Infectious Disease, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
Journal of Pharmaceutical Analysis
|December 3, 2025
Summary
Mesoporous carbon nanoparticles (MCNs) offer advanced drug delivery and therapy solutions. Their unique properties enhance drug loading, release, and biocompatibility for improved biomedical applications.
Area of Science:
- Nanotechnology and Materials Science
- Biomedical Engineering
- Drug Delivery Systems
Background:
- Mesoporous carbon nanoparticles (MCNs) possess unique structural features like high surface area and tunable pore sizes.
- These properties address limitations in conventional drug delivery, such as inefficient loading and release, and minimize side effects.
- MCNs exhibit remarkable biocompatibility, making them promising for various biomedical applications.
Purpose of the Study:
- To review the classification and research progress of MCNs.
- To summarize preparation, modification, and physicochemical properties of MCNs.
- To highlight MCNs' applications in tumor therapy, theranostics, antibacterial uses, active molecule delivery, and biological detection.
Main Methods:
- Literature review of MCNs' classification, preparation, modification, and properties.
- Analysis of MCNs' performance in diverse biomedical applications.
- Examination of MCNs' potential for clinical translation.
Main Results:
- MCNs demonstrate significant potential in enhancing drug loading and release efficiencies.
- Their application spectrum includes advanced tumor therapy, theranostics, and antibacterial strategies.
- MCNs are effective in delivering active molecules and in biological detection systems.
Conclusions:
- MCNs are versatile nanomaterials with significant advantages for biomedical applications.
- Further research and development are crucial for overcoming challenges in clinical translation.
- MCNs hold promise for revolutionizing future therapeutic and diagnostic strategies.

